Learn how 505(b)(2) oncology drugs ease shortages and what billing, coding, and workflow steps cancer centers need for safe adoption.
Jessica White, PharmD
Advertisement
Jessica White, PharmD, is Vice President, Specialty Programs & Portfolio Management at McKesson.
Articles by Jessica White, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Phase 3 LAGOON Trial Fails to Confirm Survival Benefit of Lurbinectedin in Relapsed SCLC
2
KRAS-Mutant Lung Cancer: ASCO 2026 Highlights & Emerging Therapies
3
The Gap Between What Oncologists Have Been Prescribing and What the ROS1 Data Now Supports
4
Talquetamab Plus Daratumumab Improves PFS vs SOC in R/R Multiple Myeloma
5